NCT01505400View on ClinicalTrials.gov

Integrated Molecular Profiling in Advanced Cancers Trial

Active, not recruitingOBSERVATIONAL
Enrollment

3,026

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Breast CancerNon-small Cell Lung CancerColorectal CancerGenitourinary CancerPancreatobiliary Gastrointestinal CancerUpper Aerodigestive Tract CancerGynecological CancersMelanoma CancersRare CancersUnknown Primary Cancers
Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER